News
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors
TuHURA Biosciences, Inc. appoints Dr. Craig Tendler with extensive experience in oncology drug development to its Board of Directors, enhancing advancement of cancer immunotherapy with novel technologies -
-